All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
ABMD / Abiomed Inc.
|
|
|
|
|
|
|
|
US62857M1053 / MyoKardia, Inc.
|
|
|
|
|
|
|
|
NVRO / Nevro Corp.
|
|
|
|
|
|
|
|
ABYLY / Ablynx NV
|
|
|
|
|
|
|
|
ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
SPY / SPDR S&P 500 ETF Put
|
|
|
|
|
|
|
|
IVC / Invacare Corp.
|
|
|
|
|
|
|
|
RCM / R1 RCM Inc.
|
|
|
|
|
|
|
|
ENSG / The Ensign Group, Inc.
|
|
|
|
|
|
|
|
MGLN / Magellan Health Inc
|
|
|
|
|
|
|
|
CTRE / CareTrust REIT, Inc.
|
|
|
|
|
|
|
|
ALGN / Align Technology, Inc.
|
|
|
|
|
|
|
|
SNY / Sanofi - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
AVXS / AveXis, Inc.
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ARDM / Aradigm Corp.
|
|
|
|
|
|
|
|
/ Array BioPharma, Inc.
|
|
|
|
|
|
|
|
EHTH / eHealth, Inc.
|
|
|
|
|
|
|
|
QTNT / Quotient Ltd
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
US0153511094 / Alexion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
RDUS / Radius Recycling, Inc.
|
|
|
|
|
|
|
|
AXGN / Axogen, Inc.
|
|
|
|
|
|
|
|
AERI / Aerie Pharmaceuticals Inc
|
|
|
|
|
|
|
|
CDTX / Cidara Therapeutics, Inc.
|
|
|
|
|
|
|
|
PCRX / Pacira BioSciences, Inc.
|
|
|
|
|
|
|
|
IVTY / Invuity, Inc.
|
|
|
|
|
|
|
|
QCP / Quality Care Properties, Inc.
|
|
|
|
|
|
|
|
IRMD / IRADIMED CORPORATION
|
|
|
|
|
|
|
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
ABUS / Arbutus Biopharma Corporation
|
|
|
|
|
|
|
|
CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
CIVI / Civitas Resources, Inc.
|
|
|
|
|
|
|
|
EVHC / Envision Healthcare Holdings, Inc.
|
|
|
|
|
|
|
|
PBYI / Puma Biotechnology, Inc.
|
|
|
|
|
|
|
|
GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|